Physician profile
Ann B Bird
NPI 1568438836
$1,022.81
in general payments reported to CMS, 2019-2025
14 companies · $99.99 in 2025
The $99.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $131 · 2021: $107 · 2022: $80.81 · 2023: $319 · 2024: $152 · 2025: $99.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405 · Education: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.12 |
| Education | $165.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $248.21 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $242.54 | 2019-2025 | Veozah |
| Vivus LLC | $124.97 | 2023 | Qsymia |
| Evofem Biosciences, INC. | $98.01 | 2021-2022 | |
| Hologic Sales and Service, LLC | $75.85 | 2020-2024 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Ascend Therapeutics US, LLC | $57.26 | 2019-2022 | |
| Exact Sciences Corporation | $35.49 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $28.55 | 2019-2020 | |
| Coopersurgical, INC. | $20.70 | 2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $19.51 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.99 | 2019 | |
| Conmed Corporation | $18.01 | 2024 | Airseal |
| Amag Pharmaceuticals, INC. | $18.00 | 2019 | |
| Exeltis, USA INC. | $16.72 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Bird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.